Enzolytics Inc.
ENZC · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -100% | – | -100% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | $0 | -$0 | $0 |
| % Margin | – | 58.2% | – | 91.5% |
| R&D Expenses | $0 | $0 | $1 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $2 | $2 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | -$0 |
| Operating Expenses | $0 | $2 | $3 | $2 |
| Operating Income | -$0 | -$2 | -$3 | -$1 |
| % Margin | – | -4,070% | – | -705.5% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | $0 |
| Pre-Tax Income | -$0 | -$2 | -$3 | -$1 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$0 | -$2 | -$3 | -$1 |
| % Margin | – | -4,123.1% | – | -334.5% |
| EPS | -0 | -0.001 | -0.001 | -0 |
| % Growth | 57.1% | 30% | -400% | – |
| EPS Diluted | -0 | -0.001 | -0.001 | -0 |
| Weighted Avg Shares Out | 1,292 | 2,925 | 2,823 | 2,798 |
| Weighted Avg Shares Out Dil | 1,292 | 2,925 | 2,823 | 2,798 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$0 | -$2 | -$3 | -$1 |
| % Margin | – | -4,019.3% | – | -306% |